Cargando…
269 Refractory Chronic Urticaria Treated with Omalizumab
BACKGROUND: Chronic urticaria (CU) is a common disorder characterized by recurrent episodes of urticaria pruritic erythematous lesions, associated with angioedema(1). It affects 0.1% of the population, it is estimated that approximately 15 to 25% of the population will have hives at some point in th...
Autores principales: | Saenz, Martinez, Del Pozo, Ramírez, JJ, Lopez Tiro, Vera, Javier Gomez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513034/ http://dx.doi.org/10.1097/01.WOX.0000412026.08889.ad |
Ejemplares similares
-
274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012) -
279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012) -
281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012) -
275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report
por: Varricchi, Gilda, et al.
Publicado: (2012) -
139 Genetic Association Study of the IgE Immunodeficiency in Mexican Population
por: Malpica Cruz, Jose Augusto, et al.
Publicado: (2012)